Disc Medicine Inc’s recent filing unveils that its Affiliate AI DMI LLC acquired Company’s shares for reported $0.54 million on Dec 15 ’25. In the deal valued at $92.00 per share,5,843 shares were bought.
Then, Atlas Venture Opportunity Fund bought 8,851 shares, generating $814,292 in total proceeds.
Before that, Atlas Venture Opportunity Fund bought 17,433 shares. Disc Medicine Inc shares valued at $1,603,836 were divested by the Shareholder at a price of $92.00 per share.
A number of analysts have revised their coverage, including Truist’s analysts, who began to cover the stock in late July with a ‘”a Buy”‘ rating.
Price Performance Review of IRON
On Monday, Disc Medicine Inc [NASDAQ:IRON] saw its stock jump 0.16% to $92.0. Over the last five days, the stock has lost -0.26%. Disc Medicine Inc shares have risen nearly 39.54% since the year began. Nevertheless, the stocks have risen 45.11% over the past one year. While a 52-week high of $99.50 was reached on 12/08/25, a 52-week low of $30.82 was recorded on 04/09/25.
Levels Of Support And Resistance For IRON Stock
The 24-hour chart illustrates a support level at 90.47, which if violated will result in even more drops to 88.95. On the upside, there is a resistance level at 93.06. A further resistance level may holdings at 94.13.
How much short interest is there in Disc Medicine Inc?
A steep rise in short interest was recorded in Disc Medicine Inc stocks on 2025-11-28, dropping by -0.28 million shares to a total of 2.59 million shares. Yahoo Finance data shows the prior-month short interest on 2025-10-31 was 2.87 million shares. There was a decline of -10.83%, which implies that there is a negative sentiment for the stock.
The most recent change occurred on February 27, 2025 when TD Cowen began covering the stock and recommended ‘”a Buy”‘ rating.
